Results 231 to 240 of about 232,884 (341)

Identifying and overcoming barriers to referral in advanced heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC

open access: yesEuropean Journal of Heart Failure, EarlyView.
Barriers and solutions to referral and therapy implementation in advanced heart failure. EMR, electronic medical record; HF, heart failure; HT, heart transplantation; ICARe‐HF, integrated care for advanced heart failure; LVAD, left ventricular assist device; MCS, mechanical circulatory support; OMT, optimal medical therapy; RCT, randomized controlled ...
Guillaume Baudry   +15 more
wiley   +1 more source

Finerenone according to insulin resistance in heart failure: Insights from the FINEARTS‐HF trial

open access: yesEuropean Journal of Heart Failure, EarlyView.
Insulin resistance in heart failure with mildly reduced or preserved ejection fraction: insights from FINEARTS‐HF. CI, confidence interval; CV, cardiovascular; eGDR, estimated glucose disposal rate; HF, heart failure. Aims The estimated glucose disposal rate (eGDR) is a simple, non‐invasive measure of insulin resistance. In this exploratory analysis of
John W. Ostrominski   +15 more
wiley   +1 more source

Distinct blood volume and left ventricular adaptation to severe obesity in middle‐aged adults at risk for heart failure

open access: yesEuropean Journal of Heart Failure, EarlyView.
Obesity, blood volume and ventricular remodelling. BMI, body mass index; DEXA, dual‐energy X‐ray absorptiometry; IR, increased risk; LVEDV, left ventricular end‐diastolic volume; LVEDVi, left ventricular end‐diastolic volume index. Created in BioRender. Wakeham, D.
Joseph Campain   +10 more
wiley   +1 more source

An individual treatment effect approach to predict response to mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction

open access: yesEuropean Journal of Heart Failure, EarlyView.
Aims Mineralocorticoid receptor antagonists (MRAs) are often underused in patients with heart failure (HF) and reduced ejection fraction (HFrEF). Individual treatment effect (ITE) may assist physicians in making timely decisions about which patients are the best suited for personalized therapy.
Masatake Kobayashi   +9 more
wiley   +1 more source

Bioactive Compounds Derived From Natural Foods Against Metabolic Syndrome and the Advances of Resveratrol and Caffeic Acid in Microbial Cell Factory Production: A Review

open access: yesFood Frontiers, EarlyView.
Metabolic syndrome is characterized by abdominal obesity, hyperglycemia, dyslipidemia, and hypertension. Bioactive compounds extracted from herbs, tea, and coffee using microbial cell factories, particularly resveratrol and caffeic acid, have demonstrated remarkable potential in the management of metabolic syndrome, offering innovative solutions for ...
Tao Li   +7 more
wiley   +1 more source

Blood Pressure-Lowering Effects of Aldosterone Synthase Inhibitors-A Systematic Review. [PDF]

open access: yesBasic Clin Pharmacol Toxicol
Rasmussen AA   +3 more
europepmc   +1 more source

K+ Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension

open access: yesScience, 2011
Murim Choi   +19 more
semanticscholar   +1 more source

Targeting dipeptidyl peptidase 3 (DPP3) in extreme‐critically ill patients with refractory shock: First‐in‐human report on the safety and efficacy of an anti‐DPP3 antibody

open access: yes
European Journal of Heart Failure, EarlyView.
Dominik Jarczak   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy